RB1 and sarcoma: The NGS results for this patient identified loss-of-function pathogenic variants in RB1 (p.W516*), TP53 (p.G187D), and FBXW7 (p.S294fs), which have been reported previously in FDC sarcoma patients, supporting the FDC sarcoma diagnosis.